
Molbio Diagnostics successfully raised ₹281 crore from anchor investors, including the World Bank's IFC and HDFC AMC, ahead of its public issue opening on August 10, 2026.
The company is targeting a total IPO size of ₹7,681 crore, with the anchor round signaling strong institutional confidence in the firm's diagnostic technology portfolio.
The IPO is part of a broader market rush, with nine companies collectively aiming to raise over ₹7,700 crore in the coming week despite global economic headwinds.